Organisation paid for research Program year 2025 Source: CMS Open Payments

Endocrine Research Solutions, Inc

Neither a doctor nor a teaching hospital

Research payments

$1,314,575

3,248 payments

Through program year 2025, Endocrine Research Solutions, Inc is reported as receiving $1,314,575 in research payments, across 3,248 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$27,605	7
2024	Research	$97,730	74
2023	Research	$231,218	246
2022	Research	$219,160	800
2021	Research	$373,397	1,489
2020	Research	$338,069	395
2019	Research	$27,395	237

Breakdown

Who paid Research payments · program years 2019–2025

Novo Nordisk AS $1,201,542 3,243 payments
Insulet Corporation $113,033 5 payments

Studies the money was for Research payments · program years 2019–2025

Ex9924-4473 $356,981 763 payments
Nn1436-4625 $255,274 623 payments
Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults with Type 2 Diabetes. $113,033 5 payments
Nn9536-4373 $96,355 21 payments
Nn1436-4478 $78,579 192 payments
Nn9535-4352 $68,405 249 payments
Nn9536-4375 $55,443 17 payments
Nn9924-4635 $46,482 69 payments
Nn9535-4321 $40,602 255 payments
Nn1436-4481 $38,322 283 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.